







Atlas Genet Cytogenet Oncol Haematol. 2013; 17(4)  245 
INIST-CNRS 
 
OPEN ACCESS JOURNAL 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
SLIT2 (slit homolog 2 (Drosophila)) 
Kim Brussen 
Sanquin Research and Landsteiner Laboratory, Department of Hematopoiesis, Academic Medical Center, 
University of Amsterdam, Amsterdam, The Netherlands (KB) 
 
Published in Atlas Database: October 2012 
Online updated version : http://AtlasGeneticsOncology.org/Genes/SLIT2ID42328ch4p15.html 
DOI: 10.4267/2042/48865 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2013 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Identity 
Other names: SLIL3, Slit-2 




SLIT2 is a member of the SLIT gene family. In 
mammals, this family contains 3 genes named SLIT1, 
SLIT2 and SLIT3. 
Description 
SLIT2A and SLIT2C have 37 coding exons, while 
SLIT2B has 36 coding exons, spanning 365 kb of the 
genome. All SLIT genes contain CpG islands in their 
promoter regions and intron length and exon-intron 
boundaries are highly similar (Little et al., 2002; Dallol 
et al., 2005). 
Transcription 
The leucine rich repeat regions of the three human 
SLIT genes contain a large number of very small 
exons, mostly encoding for one individual leucine rich 
repeat.  
This allows alternative splicing of the exons, without 
altering the frame (Little et al., 2002). Three 
alternatively spliced variants were identified after 
screening of a human fetal brain cDNA library and 
nucleotide database searching (Little et al., 2002). 
These variants have been described by different groups 
(Holmes et al., 1998; Itoh et al., 1998; Brose et al., 
1999). 
The transcript described by Itoh et al. (1998) was 
named SLIT2A, the transcript described by Holmes et 
al. (1998) was named SLIT2B and the transcript 
described by Brose et al. (1999) was named SLIT2C. 
SLIT2B and SLIT2C lack exon 15. This exon encodes 
for eight amino acids of unkown function (Holmes et 
al., 1998; Brose et al., 1999; Little et al., 2002). In 
addition, SLIT2C contains an additional exon. This 
exon is located in an intron between exon 8 and 9 and 
encodes for four amino acids (Little et al., 2002). 
Between transcripts, differences can also be found in 
the length of the 5'UTR and the 3'UTR. The relevance 
of the differently spliced variants is unclear. 
 
 
Genomic localization of SLIT2.  The SLIT2 gene is shown in red, the surrounding genes in grey. The arrows indicate the direction of 
transcription (NCBI, version 10 Jul 12). 
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Map of the SLIT2 gene, direction from 5'UTR till 3' UTR. The direction of transcription is indicated by the arrow. Exons are depicted as 
blue boxes. Within the first and the last exon, the 5'UTR and 3'UTR are depicted in yellow. There are three differently spliced variants of 
SLIT2, named SLIT2A, SLIT2B and SLIT2C (Holmes et al., 1998; Itoh et al., 1998; Brose et al., 1999). Exons that are only present in one 
of the transcripts are depicted in red (see below for further explanation). The length of the exons and introns is roughly indicated, but is 
not up to scale. The size of the exons ranges from 12 base pairs up to 1790 base pairs, the size of the introns ranges from 110 base 
pairs up to 198870 base pairs. For clarity, the exons are depicted larger than the introns. Below is indicated which protein domains are 
encoded by particular exons. Based on ENSEMBL version 68 Juli 2012 transcripts ENST00000504154 (SLIT2A), ENST00000503823 





The extracellular matrix protein SLIT was first 
identified in a genetic screen for mutations that affected 
the dorsal-ventral patterning or the development of the 
central nervous system in Drosophila (Anderson et al., 
1984; Seeger et al., 1993). SLIT homologues have 
since been found in C. elegans and in vertebrates, 
including mammals (Holmes et al., 1998; Itoh et al.,
1998; Brose et al., 1999; Holmes et al., 2001; 
Vargesson et al., 2001; Gilthorpe et al., 2002). The 
cognate receptor of the SLIT proteins is Roundabout or 
ROBO (Kidd et al., 1998; Huminiecki et al., 2002). 
Description 
In mammals there are three SLIT genes which encode 
large ECM glycoproteins of about 200 kDa, comprising 
a stretch of four leucine rich repeats (LRR) connected 
by disulphide bonds, seven to nine epidermal growth 
factor (EGF)-like domains, a domain named Agrin, 
Laminin, Perlecan and SLIT (ALPS) or laminin G-like 
module, and a C-terminal cystein knot (Rothberg and
Artavanis-Tsakonas, 1992; Hohenester et al., 1999; 
Nguyen-Ba-Charvet and Chedotal, 2002). SLIT 
proteins can be proteolytically cleaved within the EGF-
like region, this has been shown to occur for SLIT2 and 
for SLIT3 (Brose et al., 1999; Patel et al., 2001; 
Condac et al., 2012). Differently spliced variants of the 
SLIT2 protein exist, three of which were reported in 
literature (Itoh et al., 1998; Holmes et al., 1998; Brose 
et al., 1999). SLIT2A is 1529 amino acids long 
(ENSEMBL protein ID ENSP00000422591), SLIT2B 
is 1521 amino acids long (ENSEMBL protein ID 
ENSP00000427548) and SLIT2C is 1525 amino acids 
long (ENSEMBL protein ID ENSP00000422261). 
Expression 
In humans, SLIT2 is expressed both during embryonic 
development and during adult life. It is expressed in the 
fetal kidney and lung (Itoh et al., 1998) as well as in the 
adult kidney (Wu et al., 2001), in the female 
reproductive tract (endometrium, fallopian tube and 
ovaries) (Dickinson et al., 2008; Duncan et al., 2010; 
Dickinson et al;, 2011), the adrenal gland, the brain and 
the spinal cord (Itoh et al., 1998) and in bone marrow 
stromal and endothelial cells (Geutskens et al., 2012).  
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Domain organization of the SLIT protein from N-term inus to C-terminus.  SS: N-terminal signal peptide; LRR: leucin-rich repeat; 
EGF-like: epidermal growth factor-like domain; Lam-G like: Agrin, Laminin, Perlecan and SLIT (ALPS) or laminin G-like module; Cystein 
knot: C-terminal cystein knot. The sciccors represent a proteolytic cleavage site. Adapted from a figure created by dr. S.B. Geutskens 
(Leiden University Medical Center; Department of Immunohematology and Blood Transfusion and Einthoven laboratory for Experimental 
Vascular Medicine; Leiden; The Netherlands). 
 
For two of the differently spliced variants of SLIT2, the 
expression pattern was examined in several fetal and 
adult tissues. SLIT2A is expressed in the adult human 
spinal cord and in low levels in the fetal lung and 
kidney (Itoh et al., 1998), expression of SLIT2B can 
also be detected outside the CNS in postnatal human 
tissues (Holmes et al., 1998). SLIT2C is expressed in 
the rat spinal cord during embryonic development 
(Brose et al., 1999). The functional relevance of the
differently spliced variants is not clear. 
Localisation 
SLIT is a secreted extracellular matrix protein that is 
bound to the surface of the cell by the extracellular 
matrix, mainly by heparan sulfates (Liang et al., 1999; 
Ronca et al., 2001). It has been reported that boththe 
N-terminal part of SLIT2 (Hussain et al., 2006) and the 
C-terminal part of SLIT2 and SLIT3 bind to heparin 
and heparan sulfates (Ronca et al., 2001; Condac et l., 
2012). The interaction between SLIT proteins and 
heparan-sulfates is not only important for the binding 
of SLIT proteins to the extracellular matrix, but can 
also increase the affinity of SLIT for ROBO (Hu et al., 
2001). Removal of heparan sulfates from the cell 
surface abolishes the response to SLIT2 (Hu et al., 
2001; Hussain et al., 2006). Therefore, heparan-sulfates 
are considered as important co-receptors in SLIT-
ROBO signalling (Inatani et al., 2003; Steigemann et 
al., 2004; Hussain et al., 2006). The SLIT2 and the 
SLIT3 protein can be proteolytically cleaved. 
Following proteolytic cleavage of SLIT2, the 140kDa 
N-terminal fragment remains tightly associated to the
cell surface, while the 50-60kDa C-terminal fragment is 
more loosely attached and can also be detected in 
conditioned medium (Brose et al., 1999; Wang et al., 
1999). 
Function 
The extracellular matrix protein SLIT binds to the 
transmembrane receptor Roundabout or ROBO and has 
a conserved role in axon guidance in the central 
nervous system (CNS), where SLIT functions as a 
repellent for ROBO-expressing axons (Brose et al., 
1999; Kidd et al., 1999; Long et al., 2004). Outside the 
CNS, SLIT plays an important role during embryonic 
development and in human pathology. 
Neuronal guidance: SLIT proteins function as 
chemorepellents throughout the central nervous system 
to restrict the positioning of axons to their proper sites. 
Deletion of SLIT2 resulted in defects in cortical 
inhibitory neurons, commisural neurons and sensory 
neurons (Nguyen-Ba-Charvet et al., 1999; Bagri et al., 
2002; Nguyen-Ba-Charvet et al., 2002; Plump et al., 
2002; Long et al., 2004; Unni et al., 2012). Cortical 
inhibitory neurons (interneurons) modulate the 
response of pyramidal cells to incoming signals, 
thereby preventing overexcitation and maintaining the
balance between different signals. In rodents, they ar  
generated in the ventral telencephalon whereafter th y
migrate into the cortex (reviewed by Rossignol, 2011). 
Slit1/2 double knockout mice display an increased 
interneuron proliferation and an increase in neuronal 
process length and branching (Andrews et al., 2008). 
Vertebrate commissural neurons first arise in the dorsal 
spinal cord. Their axons are directed to the midline/ 
floorplate by the chemoattractants netrin and sonic 
hedgehog. When these axons have reached the midline, 
they cross it and turn longitudinally on the opposite 
side, growing right alongside the midline/ floor plate 
(reviewed by Dickson and Gilestro, 2006). Bagri et al. 
(2002) reported a broad spectrum of neuronal defects in 
Slit2 knockout or Slit1/Slit2 double knockout mice. 
Without SLIT2, axons project erronuously in ventral 
and medial directions. Without SLIT1 and SLIT2, 
axons also travel to and cross the midline. These 
defects occured in corticofugal, thalamocortical, and 
callosal tracts (Bagri et al., 2002). The corpus callosum 
defects were further investigated by Unni et al. (2012). 
In Slit2 knockout mice, defects in corpus callosum 
formation occurred. Axons stalled at the midline or 
projected aberrantly. There was no phenotype in Slit1 
knockout mice and only a mild phenotype in Slit3 
knockout mice, but in Slit1/Slit2 double knockout mice 
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the phenotype was more severe than in Slit2 knockout 
mice. In addition, in both Slit2 knockout and Slit1/2 
double knockout mice, there was a mispositioning of 
glial cells (Unni et al., 2012). In Slit1/2/3 triple 
knockout mice, 72% of commisural axons failed to 
leave the midline and 20% recrossed the midline (Long 
et al., 2004). Olfactory sensory neurons located in the 
olfactory epithelium pick up different odors and 
translate these odors into sensory information for the 
brain. Axons from the sensory neurons project into the 
olfactory bulb (OB) into separate units that are spcific 
for one odor, the glomeruli. Dendrites from mitral and 
tufted cells transmit the information from the different 
glomeruli to the olfactory cortex of the brain.  
The olfactory system is organized into distinct regions. 
Odorants activate a typical pattern of glomeruli in 
different regions of the OB. The distinct patterning of 
the OB and the type and place of the activated 
glomeruli determine the behavior elicited by an odorant 
(Reviewed by Mori and Sakano, 2011).  
In the developing mouse and rat olfactory system, Slit2
is the first repellent expressed in the septum, Slit1 
follows. From E14 to E18, both are expressed in the 
midline of the telencephalon including the septum. At 
this stage, Robo2 is expressed by tufted and mitral cells 
in the OB. In vitro, SLIT1 and SLIT2 repelled OB 
axons (Nguyen-Ba-Charvet et al., 1999; Nguyen-Ba-
Charvet et al., 2002). Moreover, in Slit1 and Slit2 
double KO mice, axons were not repelled by the 
midline and the septum. Correspondingly, the lateral 
olfactory tract (LOT) was increased in size.  
No defects were found in Slit1 or Slit2 single KO mice 
(Nguyen-Ba-Charvet et al., 2002). Sensory neurons in 
the visual pathway were also affected by Slit factors. In 
Slit1/Slit2 knockout mice a second optic chiasm was 
formed with aberrantly projecting axons (Plump et al., 
2002). 
Kidney development: Development of the kidney is 
initiated by the Wolfferian duct, which forms the 
ureteric bud. The ureteric bud branches and further 
develops in the ureters and the kidney. An important 
growth factor during bud development is the TGF-β 
family member glial cell-line-derived neurotrophic 
factor (GDNF), which signals through a receptor 
kinase, RET and is restricted to the site of ureteric bud 
development.  
Defects in ureteric bud development can result in 
malformation of the kidney or ureters, renal agenesis or 
a reduced number of nephrons (Costantini and Shakya, 
2006).  
In Slit2 mutant embryos, GDNF expression was not 
restricted to the site of bud development and an 
additional ureteric bud developed.  
This resulted in the development of two or more ureters 
or kidneys at the same site. The ureters failed to 
connect to the bladder and the collecting ducts and the 
ureter were dilated. Later during development, in some 
of the embryos the kidneys fused. Nephron formation  
was expanded from the periphery to the interior of the 
kidney. Consequently, the mice did not survive after 
birth (Grieshammer et al., 2004). 
Migration: SLITs not only regulate migration and 
differentiation during embryogenesis, but also during 
adult life. SLIT2 has been shown to inhibit the 
chemotaxis of peripheral blood mononuclear cells, 
leukocytes, neutrophils, macrophages, lymphocytes and 
dendritic cells both in vitro and in vivo (Wu et al., 
2001; Guan et al., 2003; Chen et al., 2004; Kanellis t 
al., 2004; Prasad et al., 2007; Tole et al., 2009; Ye et 
al., 2010), while it enhanced the chemotaxis of 
eosinophils in vivo (Ye et al., 2010).  
In some cell types, such as endothelial cells, the 
response to SLIT2 is more variable (Wang et al., 2003; 
Kaur et al., 2008). The differential response of cells to 
SLIT2 may be explained in part by cell-specific 
downstream signaling cues. Ye et al. have shown that 
the level of the SLIT-ROBO GTPase activating protein 
1 is lower in eosinophils than in neutrophils. As a 
consequence, CDC42 and PI3K are activated in 
eosinophils, resulting in enhanced chemotaxis, whereas 
CDC42 is inactivated in neutrophils, leading to 
inhibition of chemotaxis (Ye et al., 2010). 
Osteoblast differentiation: SLIT2 has also been 
implicated in the regulation of osteoblast 
differentiation. Sun et al. (2009) reported that 
osteogenic differentiation was inhibited by SLIT2 in 
vitro (Sun et al., 2009). 
Homology 
A single slit gene was isolated in invertebrates, whereas 
there are three SLIT genes in mammals. The human 
SLIT2 protein shows 44,3 sequence homology to 
Drosophila Slit (Itoh et al., 1998; Brose et al., 1999), 
65% homology to the human SLIT1 protein (NCBI 
accession BAA35184.1, NCBI protein blast) and 67% 
homology to the human SLIT3 protein (NCBI 




86% of medulloblastoma tumors express SLIT2, which 
is not silenced by methylation of the CpG islands.  
Interestingly, administration of recombinant SLIT2 
protein to medulloblastoma spheroids could inhibit 
tumor cell invasion without affecting cell direction or 
proliferation. Treatment with SLIT2 conditioned media 
resulted in reduced CDC42 activation and moderately 
reduced Rac1 activation. There was no effect on RhoA 
activity (Werbowetski-Ogilvie et al., 2006). 
Glioma 
Note 
Dallol et al. (2003) detected methylation of the CpG 
islands in the SLIT2 promoter in 59% of gliomas and in  
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71% of the tested glioma cell lines. 66,7% of the 
gliomas were classified as glioblastoma multiforme, th  
most malignant stage, the rest was randomly collected.  
Promoter methylation correlated with reduced SLIT2 
expression. Exogenous expression of SLIT2 in a 
methylated glioma cell line suppressed tumor growth in 
a colony formation assay (Dallol et al., 2003).  
In another study, administration of SLIT2 to glioma 
spheroids of a non-methylated cell line did not affect 
tumor invasion (Werbowetski-Ogilvie et al., 2006). 
Colorectal carcinoma 
Note 
In 72% of colorectal carcinomas, methylation of the 
SLIT2 promoter was found, which correlated with 
abolished expression of SLIT2. Exogenous expression 
of SLIT2 in two methylated colorectal tumor cell lines 
suppressed tumor growth in a colony formation assay.  
In addition, administration of SLIT2 conditioned 
medium suppressed tumor growth and induced 
apoptosis in a methylated colorectal tumor cell line 
(Dallol et al., 2003).  
In contrast, Wang et al. (2003) reported that SLIT2 
expression was not detected in normal and hyperplastic 
colon tissues, was moderately detected in colon 
adenomas (21,4%) and was upregulated in 64,6% of 
colon carcinomas.  
SLIT2 expression appeared to be enhanced in areas of 
high tumor cell and vessel density. Blood vessel growth 
and tumor volume increased in athymic nude mice 
injected with melanoma cells that overexpress SLIT2, 
but it was not investigated whether this occurs in colon 
cancer cells (Wang et al., 2003). 
Lung cancer 
Note 
Methylation of the SLIT2 promoter was found in 53% 
of primary non-small cell lung cancer (NSCLC) 
tumors, in 77% of NSCLC cell lines, in 36% of primary 
small cell lung cancer (SCLC) tumors and in 55% of 
SCLC cell lines (Dallol et al., 2002; Tseng et al.,2010), 
which correlated with reduced SLIT2 expression 
(Tseng et al., 2010). Furthermore, low SLIT2 
expression correlated with a poor prognosis and lower 
disease-free survival rates in NSCLC patients.  
For patients with metastasis, the poor survival rate 
correlated not only with low SLIT2 expression but also 
with accumulation of β-catenin (Tseng et al., 2010).  
When SLIT2 was re-expressed after treatment with 
demethylating agents, the migration of lung cancer 
cells decreased, while β-catenin-E-cadherin association 
was enhanced.  
Moreover, migration was also inhibited when the cells 
were treated with SLIT2 conditioned media or after 
exogenous expression of SLIT2 in the cells. Besides 
reduced migration, these cells had increased E-cadherin 
and decreased SNAI1 levels. On the contrary, after 
knock down of SLIT2, migration was increased while 
cell adhesion was reduced. Reduced cell adhesion was 
attributed to deregulation of β-catenin and E-cadherin/ 
SNAI1 (Tseng et al., 2010). 
Breast cancer 
Note 
Methylation of the SLIT2 promoter was discovered in  
43% of breast cancer primary tumors and in 59% of 
breast cancer cell lines, which correlated with reduced 
SLIT2 expression in these tumors. In breast tumor cell 
lines, both overexpression of SLIT2 and treatment with
SLIT2 conditioned media suppressed tumor cell growth 
in an in vitro colony assay (Dallol et al., 2002).  
Overexpression of SLIT2 also reduced proliferation 
and migration in vitro (Prasad et al., 2008). There was 
no effect on breast cancer cell lines with a normal 
expression level of SLIT2 (Dallol et al., 2002).  
In mice injected with SLIT2 overexpressing MCF-7 
breast cancer cells, tumor size was reduced (Prasad et 
al., 2008). The tumor-suppressive effect of SLIT2 may 
be mediated via 2 different mechanisms, namely 
through the modulation of β-catenin signaling and 
through the modulation of CXCL12/ CXCR4-signaling.  
Overexpression of SLIT2 resulted in increased cell-ll 
adhesion due to enhanced β-catenin-E-cadherin 
association. This was combined with decreased 
expression of β-catenin and target genes of β-catenin, 
decreased nuclear translocation of β-catenin and 
increased expression of E-cadherin (Prasad et al., 
2008).  
Several studies found a correlation between CXCR4 
and SLIT expression in breast cancer cells. Loss of 
SLIT2 and SLIT3 expression correlated with the 
upregulation of CXCR4 and resulted in hyperplastic 
lesions and in desmoplastic stroma in mouse mammary 
gland and in human MCF7 breast cancer cells.  
Overexpression of SLIT2 or SLIT3 in human breast 
carcinoma MDA-MB-231 cells resulted in a down-
regulation of CXCR4 expression, reduced colony 
formation in vitro and in inhibition of tumor growth in 
a xenograft model in vivo.  
Furthermore, SLIT2 addition inhibited CXCL12/ 
CXCR4-induced breast cancer cell chemotaxis, chemo-
invasion and adhesion.  
 
SLIT2 affects CXCR4 signaling via the inhibition of
CXCL12-induced phosporylation of focal adhesion 
components and the inhibition of PI3K, MAPK and 
metallo-protease activity (Prasad et al., 2004, Marlow 
et al., 2008). 
Melanoma 
Note 
SLIT2 was expressed in 42,9% of melanomas, while 
SLIT2 was not expressed in nearby normal tissue. 
Blood vessel growth and tumor volume increased in 
athymic nude mice injected with melanoma cells that 
overexpress SLIT2, while both were decreased when 
SLIT-ROBO signaling was inhibited by ectopic 
expression of ROBON, an extracellular fragment which 
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contains the SLIT-binding domain of ROBO1 and 
functions as scavenger for SLIT proteins, or the us of 
R5, an antibody directed against the SLIT-binding 
domain of ROBO1 (Wang et al., 2003). 
Lymphatic metastasis of pancreatic islet 
tumors 
Note 
Administration of SLIT2 to human lymphatic 
endothelial cells (hLEC) resulted in enhanced tubular 
formation and in increased migration, while there was 
no effect on the proliferation of the cells. 
Overexpression of Slit2 resulted in an increase of 
lymphatic vessel length in the pancreas. When Slit2 
transgenic mice were crossed with the non-metastatic 
pancreatic islet tumor mouse line RIP1-Tag2, tumor 
lymphangiogenesis was increased and metastases in the
regional mesentheric lymph nodes and in the intestin  
were found. Although some metastases were found in 
control mice, metastasis formation was higher in mice 
that overexpress Slit2 and overall survival was 
decreased (Yang et al., 2010). 
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